Xi'an Medical University Report issue

Academic/Hospital Phase 3 Phase 4

Organization Overview

First Clinical Trial
2017
NCT03110341
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Second Affiliated Hospital of Xi'an Medical University | The First Affiliated Hospital of Xi'an Medical University

Active Ingredients

Drugs in Phase 4 Trials (1)

acetylsalicylic acid (aspirin) (1 trial)

Drugs in Phase 3 Trials (1)

epoetin (Epogen) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cerebral Infarction (Phase 4)

Cerebral Palsy (Phase 3)

Hemorrhage (Phase 3)

Intracranial Hemorrhages (Phase 3)

Ischemia (Phase 4)

Leukomalacia, Periventricular (Phase 3)

Premature Birth (Phase 3)

Stroke (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 2